Black Diamond Therapeutics
Latest round
- Series C
Last raised
- Dec 2019
Total raised
- $148M
Investors
- 15
About Black Diamond Therapeutics
Black Diamond Therapeutics, Inc.Founded in 2014 and headquartered in Cambridge, US, Black Diamond Therapeutics, Inc. specializes in oncology therapeutics. The company's founders, Elizabeth Buck and Garry Menzel, brought extensive expertise in drug development.Black Diamond Therapeutics develops therapies targeting non-small cell lung cancer (NSCLC) and glioblastoma (GBM) using its MasterKey approach. Its products, including Silevertinib for NSCLC and GBM, as well as candidates like BDTX-4933 and BDTX-4876, are aimed at overcoming drug resistance and minimizing side effects.78 mn for the year 2024. The firm is focused on launching new therapies and expanding into additional geographic markets by the end of 2024.
Who invested in Black Diamond Therapeutics
15 investors across 3 rounds
See all investors in Black Diamond Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Black Diamond Therapeutics
Who invested in Black Diamond Therapeutics?
Black Diamond Therapeutics has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Black Diamond Therapeutics raised?
Black Diamond Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Black Diamond Therapeutics last raise money?
Black Diamond Therapeutics's most recent round on record is a Series C, in Dec 2019.
What does Black Diamond Therapeutics do?
Black Diamond Therapeutics, Inc.
Where is Black Diamond Therapeutics headquartered?
Black Diamond Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Black Diamond Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Black Diamond Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Black Diamond Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.